Cargando…
Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
BACKGROUND: Cirrhosis patients are prescribed multiple medications for their liver disease and comorbidities. Discrepancies between medicines consumed by patients and those documented in the medical record may contribute to patient harm and impair disease management. The aim of the present study was...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020443/ https://www.ncbi.nlm.nih.gov/pubmed/27618841 http://dx.doi.org/10.1186/s12876-016-0530-4 |
_version_ | 1782453202149441536 |
---|---|
author | Hayward, Kelly L. Valery, Patricia C. Cottrell, W. Neil Irvine, Katharine M. Horsfall, Leigh U. Tallis, Caroline J. Chachay, Veronique S. Ruffin, Brittany J Martin, Jennifer H. Powell, Elizabeth E. |
author_facet | Hayward, Kelly L. Valery, Patricia C. Cottrell, W. Neil Irvine, Katharine M. Horsfall, Leigh U. Tallis, Caroline J. Chachay, Veronique S. Ruffin, Brittany J Martin, Jennifer H. Powell, Elizabeth E. |
author_sort | Hayward, Kelly L. |
collection | PubMed |
description | BACKGROUND: Cirrhosis patients are prescribed multiple medications for their liver disease and comorbidities. Discrepancies between medicines consumed by patients and those documented in the medical record may contribute to patient harm and impair disease management. The aim of the present study was to assess the magnitude and types of discrepancies among patient-reported and medical record-documented medications in patients with cirrhosis, and examine factors associated with such discrepancies. METHODS: Fifty patients who attended a hospital hepatology outpatient clinic were interviewed using a questionnaire composed of mixed short-response and multiple-choice questions. Patients’ reported medication use was compared with documentation in the hospital medical records and pharmacy database. Medication adherence was assessed using the 8-question ©Morisky Medication Adherence Scale (MMAS-8). The multivariate logistic regression model was constructed using clinically relevant and/or statistically significant variables as determined by univariate analysis. All p-values were 2-sided (α = 0.05). RESULTS: Twenty-seven patients (54.0 %) had ≥1 discrepancy between reported and documented medicines. Patients with ≥1 discrepancy were older (p = 0.04) and multivariate analysis identified taking ≥5 conventional medicines or having a ‘low’ or ‘medium’ adherence ranking as independent predictors of discrepancy (adjusted OR 11.0 (95 % CI 1.8–67.4), 20.7 (95 % CI 1.3–337.7) and 49.0 (95 % CI 3.3–718.5) respectively). Concordance was highest for liver disease medicines (71.9 %) and lowest for complementary and alternative medicines (14.5 %) and respiratory medicines (0 %). CONCLUSION: There is significant discrepancy between sources of patient medication information within the hepatology clinic. Medication reconciliation and medicines-management intervention may address the complex relationship between medication discrepancies, number of medications and patient adherence identified in this study. |
format | Online Article Text |
id | pubmed-5020443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50204432016-09-14 Prevalence of medication discrepancies in patients with cirrhosis: a pilot study Hayward, Kelly L. Valery, Patricia C. Cottrell, W. Neil Irvine, Katharine M. Horsfall, Leigh U. Tallis, Caroline J. Chachay, Veronique S. Ruffin, Brittany J Martin, Jennifer H. Powell, Elizabeth E. BMC Gastroenterol Research Article BACKGROUND: Cirrhosis patients are prescribed multiple medications for their liver disease and comorbidities. Discrepancies between medicines consumed by patients and those documented in the medical record may contribute to patient harm and impair disease management. The aim of the present study was to assess the magnitude and types of discrepancies among patient-reported and medical record-documented medications in patients with cirrhosis, and examine factors associated with such discrepancies. METHODS: Fifty patients who attended a hospital hepatology outpatient clinic were interviewed using a questionnaire composed of mixed short-response and multiple-choice questions. Patients’ reported medication use was compared with documentation in the hospital medical records and pharmacy database. Medication adherence was assessed using the 8-question ©Morisky Medication Adherence Scale (MMAS-8). The multivariate logistic regression model was constructed using clinically relevant and/or statistically significant variables as determined by univariate analysis. All p-values were 2-sided (α = 0.05). RESULTS: Twenty-seven patients (54.0 %) had ≥1 discrepancy between reported and documented medicines. Patients with ≥1 discrepancy were older (p = 0.04) and multivariate analysis identified taking ≥5 conventional medicines or having a ‘low’ or ‘medium’ adherence ranking as independent predictors of discrepancy (adjusted OR 11.0 (95 % CI 1.8–67.4), 20.7 (95 % CI 1.3–337.7) and 49.0 (95 % CI 3.3–718.5) respectively). Concordance was highest for liver disease medicines (71.9 %) and lowest for complementary and alternative medicines (14.5 %) and respiratory medicines (0 %). CONCLUSION: There is significant discrepancy between sources of patient medication information within the hepatology clinic. Medication reconciliation and medicines-management intervention may address the complex relationship between medication discrepancies, number of medications and patient adherence identified in this study. BioMed Central 2016-09-13 /pmc/articles/PMC5020443/ /pubmed/27618841 http://dx.doi.org/10.1186/s12876-016-0530-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Hayward, Kelly L. Valery, Patricia C. Cottrell, W. Neil Irvine, Katharine M. Horsfall, Leigh U. Tallis, Caroline J. Chachay, Veronique S. Ruffin, Brittany J Martin, Jennifer H. Powell, Elizabeth E. Prevalence of medication discrepancies in patients with cirrhosis: a pilot study |
title | Prevalence of medication discrepancies in patients with cirrhosis: a pilot study |
title_full | Prevalence of medication discrepancies in patients with cirrhosis: a pilot study |
title_fullStr | Prevalence of medication discrepancies in patients with cirrhosis: a pilot study |
title_full_unstemmed | Prevalence of medication discrepancies in patients with cirrhosis: a pilot study |
title_short | Prevalence of medication discrepancies in patients with cirrhosis: a pilot study |
title_sort | prevalence of medication discrepancies in patients with cirrhosis: a pilot study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020443/ https://www.ncbi.nlm.nih.gov/pubmed/27618841 http://dx.doi.org/10.1186/s12876-016-0530-4 |
work_keys_str_mv | AT haywardkellyl prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy AT valerypatriciac prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy AT cottrellwneil prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy AT irvinekatharinem prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy AT horsfallleighu prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy AT talliscarolinej prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy AT chachayveroniques prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy AT ruffinbrittanyj prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy AT martinjenniferh prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy AT powellelizabethe prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy |